Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrentClostridium difficileinfection

Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrentClostridium difficileinfection - an observational cohort study

(2014) R. Satokari et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study

(2014) Ilan Youngster et al.   CLINICAL INFECTIOUS DISEASES

Oral, Capsulized, Frozen Fecal Microbiota Transplantation for RelapsingClostridium difficileInfection

(2014) Ilan Youngster et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Fecal Microbiota Transplantation for the Treatment of Clostridium difficile Infection

(2014) Giovanni Cammarota et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Calprotectin and Lactoferrin Faecal Levels in Patients with Clostridium difficile Infection (CDI): A Prospective Cohort Study

(2014) Andrew Swale et al.   PLoS One

Guidelines for Diagnosis, Treatment and Prevention of Clostridium difficile Infections

(2013) Christina M Surawicz et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy

(2013) Mark A Miller et al.   BMC INFECTIOUS DISEASES

Is Fidaxomicin Worth the Cost? An Economic Analysis

(2013) Sarah M. Bartsch et al.   CLINICAL INFECTIOUS DISEASES

European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection

(2013) S.B. Debast et al.   CLINICAL MICROBIOLOGY AND INFECTION

Resolution of Severe Clostridium difficile Infection Following Sequential Fecal Microbiota Transplantation

(2013) Alexa R. Weingarden et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

(2013) Els van Nood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials

(2012) Derrick W. Crook et al.   CLINICAL INFECTIOUS DISEASES

Can we identify patients at high risk of recurrent Clostridium difficile infection?

(2012) C.P. Kelly   CLINICAL MICROBIOLOGY AND INFECTION

Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence

(2012) Konstantinos Z. Vardakas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection

(2011) Ethan Gough et al.   CLINICAL INFECTIOUS DISEASES

Clostridium difficile infection

(2011) Andrea Lo Vecchio et al.   CURRENT OPINION IN GASTROENTEROLOGY

Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection

(2011) Eero Mattila et al.   GASTROENTEROLOGY

Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection

(2011) Caitlin R. Musgrave et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clostridium difficile infection in Europe: a hospital-based survey

(2010) Martijn P Bauer et al.   LANCET

Clostridium difficile infection: epidemiology, risk factors and management

(2010) Ashwin N. Ananthakrishnan   Nature Reviews Gastroenterology & Hepatology

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)

(2009) M.P. Bauer et al.   CLINICAL MICROBIOLOGY AND INFECTION

Predictors of serious complications due toClostridium difficileinfection

(2008) D. GUJJA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Case for Vancomycin as the Preferred Drug for Treatment ofClostridium difficileInfection

(2008) John G. Bartlett   CLINICAL INFECTIOUS DISEASES

Clostridium difficile— More Difficult Than Ever

(2008) Ciarán P. Kelly et al.   NEW ENGLAND JOURNAL OF MEDICINE